Challenges to Providing Integrated HIV Prevention in Substance Use Treatment Settings: Frontline Staff Perspectives on HIV and Sex-Related, Education, Communication and Stigma

References

• AIDSVu. (2021a). Local Data: Newark (2019). https://aidsvu.org/local-data/united-states/northeast/new-jersey/newark/#new-hiv-diagnoses
   Google Scholar
• AIDSVu. (2021b). Local Data: United States (2019). https://aidsvu.org/local-data/united-states/
   Google Scholar
• Alpren, C., Dawson, E. L., John, B., Cranston, K., Panneer, N., Fukuda, H. D., Roosevelt, K., Klevens, R. M., Bryant, J., Peters, P. J., Lyss, S. B., Switzer, W. M., Burrage, A., Murray, A., Agnew-Brune, C., Stiles, T., McClung, P., Campbell, E. M., Breen, C., … Buchacz, K. (2020). Opioid use fueling HIV transmission in an urban setting: An outbreak of HIV infection among people who inject drugs—Massachusetts, 2015–2018. American Journal of Public Health, 110(1), 37–44. https://doi.org/10.2105/AJPH.2019.305366
   PubMed Web of Science ®Google Scholar
• American Society of Addiction Medicine. (2021). Public policy statement on the regulation of the treatment of opioid use disorder with methadone.
   Google Scholar
• Baker, P., Beletsky, L., Avalos, L., Venegas, C., Rivera, C., Strathdee, S. A., & Cepeda, J. (2020). Policing practices and risk of HIV infection among people who inject drugs. Epidemiologic Reviews, 42(1), 27–40. https://doi.org/10.1093/epirev/mxaa010
   PubMed Web of Science ®Google Scholar
• Bazzi, A. R., Biancarelli, D. L., Childs, E., Drainoni, M. L., Edeza, A., Salhaney, P., Mimiaga, M. J., & Biello, K. B. (2018). Limited knowledge and mixed interest in pre-exposure prophylaxis for HIV ­prevention among people who inject drugs. AIDS Patient Care and STDs, 32(12), 529–537. https://doi.org/10.1089/apc.2018.0126
   PubMed Web of Science ®Google Scholar
• Behrends, C. N., Kapadia, S. N., Schackman, B. R., & Frimpong, J. A. (2021). Addressing barriers to on-site HIV and HCV testing services in methadone maintenance treatment programs in the United States: Findings from a national multisite qualitative study. Journal of Public Health Management and Practice, 27(4), 393–402. https://doi.org/10.1097/PHH.0000000000001262
   PubMed Web of Science ®Google Scholar
• Biello, K. B., Bazzi, A. R., Mimiaga, M. J., Biancarelli, D. L., Edeza, A., Salhaney, P., Childs, E., & Drainoni, M. L. (2018). Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduction Journal, 15(1), 55. https://doi.org/10.1186/s12954-018-0263-5
   PubMed Web of Science ®Google Scholar
• Broz, D., Wejnert, C., Pham, H. T., DiNenno, E., Heffelfinger, J. D., Cribbin, M., Krishna, N., Teshale, E. H., & Paz-Bailey, G. (2014). HIV infection and risk, prevention, and testing behaviors among injecting drug users—National HIV Behavioral Surveillance System, 20 U.S. cities, 2009. Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C), 63(6), 1–51.
   PubMed Web of Science ®Google Scholar
• Bruce, R. D. (2010). Methadone as HIV prevention: High volume methadone sites to decrease HIV incidence rates in resource limited settings. The International Journal on Drug Policy, 21(2), 122–124. https://doi.org/10.1016/j.drugpo.2009.10.004
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). (2015). Sexually transmitted diseases treatment guidelines. MMWR Recommendations and Reports, 64(No. RR-3), 1–137.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). (2020a). HIV infection risk, prevention, and testing behaviors among persons who inject drugs—National HIV behavioral surveillance: Injection drug use, 23 U.S. cities, 2018 (HIV Surveillance Special Report 24). https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-special-report-number-24.pdf
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2020b). 2018 updated No (31). HIV surveillance report. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2021a). HIV and substance use. https://www.cdc.gov/hiv/basics/hiv-transmission/substance-use.html
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2021b). HIV surveillance report, 2019 (No. 32). https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2018-updated-vol-32.pdf
   Google Scholar
• Edelman, E. J., Moore, B. A., Calabrese, S. K., Berkenblit, G., Cunningham, C., Patel, V., Phillips, K., Tetrault, J. M., Shah, M., Fiellin, D. A., & Blackstock, O. (2017). Primary care physicians’ willingness to prescribe HIV pre-exposure prophylaxis for people who inject drugs. AIDS and Behavior, 21(4), 1025–1033. https://doi.org/10.1007/s10461-016-1612-6
   PubMed Web of Science ®Google Scholar
• Edeza, A., Bazzi, A., Salhaney, P., Biancarelli, D., Childs, E., Mimiaga, M. J., Drainoni, M.-L., & Biello, K. (2020). HIV pre-exposure prophylaxis for people who inject drugs: The context of co-occurring injection- and sexual-related HIV risk in the U.S. Northeast. Substance Use & Misuse, 55(4), 525–533. https://doi.org/10.1080/10826084.2019.1673419
   PubMed Web of Science ®Google Scholar
• Flath, N., Tobin, K., King, K., Lee, A., & Latkin, C. (2017). Enduring consequences from the war on drugs: How policing practices impact HIV risk among people who inject drugs in Baltimore City. Substance Use & Misuse, 52(8), 1003–1010. https://doi.org/10.1080/10826084.2016.1268630
   PubMed Web of Science ®Google Scholar
• Gowing, L. R., Farrell, M., Bornemann, R., Sullivan, L. E., & Ali, R. L. (2006). Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection. Journal of General Internal Medicine, 21(2), 193–195. https://doi.org/10.1111/j.1525-1497.2005.00287.x
   PubMed Web of Science ®Google Scholar
• Griffin, M., Jaiswal, J., King, D., Singer, S. N., & Halkitis, P. N. (2020). Sexuality disclosure, trust, and satisfaction with primary care among urban young adult sexual minority men. The Journal for Nurse Practitioners, 16(5), 378–387. https://doi.org/10.1016/j.nurpra.2020.02.001
   Google Scholar
• Guise, A., Seguin, M., Mburu, G., McLean, S., Grenfell, P., Islam, Z., Filippovych, S., Assan, H., Low, A., Vickerman, P., & Rhodes, T. (2017). Integrated opioid substitution therapy and HIV care: A qualitative systematic review and synthesis of client and provider experiences. AIDS Care, 29(9), 1119–1128. https://doi.org/10.1080/09540121.2017.1300634
   PubMed Web of Science ®Google Scholar
• Harris, J., & McElrath, K. (2012). Methadone as social control: Institutionalized stigma and the prospect of recovery. Qualitative Health Research, 22(6), 810–824. https://doi.org/10.1177/1049732311432718
   PubMed Web of Science ®Google Scholar
• Hart, C. L., & Hart, M. Z. (2019). Opioid crisis: Another mechanism used to perpetuate American racism. Cultural Diversity & Ethnic Minority Psychology, 25(1), 6–11. https://doi.org/10.1037/cdp0000260
   PubMed Web of Science ®Google Scholar
• Herling, J. (2021). “Oh you should talk to…”: The implementation of LGBTQ health curricula in medical education. In A. J. LeBlanc & B. L. Perry (Eds.), Sexual and gender minority health (Vol. 21, pp. 277–298). Emerald Publishing Limited. https://doi.org/10.1108/S1057-629020210000021017
   Google Scholar
• Hussein, J., & Ferguson, L. (2019). Eliminating stigma and discrimination in sexual and reproductive health care: A public health imperative. Sexual and Reproductive Health Matters, 27(3), 1–5. https://doi.org/10.1080/26410397.2019.1697103
   PubMed Web of Science ®Google Scholar
• Jaiswal, J., Dunlap, K., Griffin, M., Cox, A., Singer, S. N., Hascher, K., LoSchiavo, C., Walters, S. M., & Mumba, M. (2021). Pre-exposure prophylaxis awareness, acceptability and potential stigma among medical and non-medical clinic staff in methadone treatment settings in northern New Jersey: The key role of non-medical staff in enhancing HIV prevention. Journal of Substance Abuse Treatment, 129, 108371. https://doi.org/10.1016/j.jsat.2021.108371
   PubMed Web of Science ®Google Scholar
• Jaiswal, J., Griffin, M., Hascher, K., Cox, A. B., Dunlap, K., Walters, S., LoSchiavo, C., Burton, W. M., & Mumba, M. (2022). Logistical facilitators and barriers to PrEP implementation in methadone clinic settings: Provider and staff perspectives. Journal of Addiction Medicine, 16(5), e278–e283. https://doi.org/10.1097/ADM.0000000000000973
   PubMed Web of Science ®Google Scholar
• Karki, P., Shrestha, R., Huedo-Medina, T. B., & Copenhaver, M. (2016). The impact of methadone maintenance treatment on HIV risk behaviors among high-risk injection drug users: A systematic review. Evidence-Based Medicine & Public Health, 2, e1229.
   PubMedGoogle Scholar
• Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. Sage.
   Google Scholar
• Lindsay, D. L., Hagle, H., Lincoln, P., Williams, J., & Luongo, P. F. (2017). Exploring medical students’ conceptions of substance use: A follow-up evaluation. Substance Abuse, 38(4), 464–467. https://doi.org/10.1080/08897077.2017.1342735
   PubMed Web of Science ®Google Scholar
• Marchand, K., Foreman, J., MacDonald, S., Harrison, S., Schechter, M. T., & Oviedo-Joekes, E. (2020). Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment. Substance Abuse Treatment, Prevention, and Policy, 15(1), 7. https://doi.org/10.1186/s13011-020-0253-y
   PubMed Web of Science ®Google Scholar
• Mohd Salleh, N. A., Voon, P., Karamouzian, M., Milloy, M.-J J., & Richardson, L. (2021). Methadone maintenance therapy service components linked to improvements in HIV care cascade outcomes: A systematic review of trials and observational studies. Drug and Alcohol Dependence, 218, 108342–108342. https://doi.org/10.1016/j.drugalcdep.2020.108342
   PubMed Web of Science ®Google Scholar
• Nieweglowski, K., Corrigan, P. W., Tyas, T., Tooley, A., Dubke, R., Lara, J., Washington, L., Sayer, J., & Sheehan, L. (2018). Exploring the public stigma of substance use disorder through community-based participatory research. Addiction Research & Theory, 26(4), 323–329. https://doi.org/10.1080/16066359.2017.1409890
   Web of Science ®Google Scholar
• Oldfield, B. J., Muñoz, N., McGovern, M. P., Funaro, M., Villanueva, M., Tetrault, J. M., & Edelman, E. J. (2019). Integration of care for HIV and opioid use disorder. AIDS (London, England), 33(5), 873–884. https://doi.org/10.1097/QAD.0000000000002125
   PubMed Web of Science ®Google Scholar
• Rich, K. M., Bia, J., Altice, F. L., & Feinberg, J. (2018). Integrated models of care for individuals with opioid use disorder: How do we prevent HIV and HCV? Current HIV/AIDS Reports, 15(3), 266–275. https://doi.org/10.1007/s11904-018-0396-x
   PubMed Web of Science ®Google Scholar
• Sherman, S. G., Schneider, K. E., Nyeong Park, J., Allen, S. T., Hunt, D., Chaulk, C. P., & Weir, B. W. (2019). PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland. Drug and Alcohol Dependence, 195, 148–155. https://doi.org/10.1016/j.drugalcdep.2018.08.014
   PubMed Web of Science ®Google Scholar
• Shrestha, R., Altice, F. L., Karki, P., & Copenhaver, M. M. (2018). Integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and reduce HIV risk in people who use drugs: A pilot feasibility study. AIDS and Behavior, 22(8), 2640–2649. https://doi.org/10.1007/s10461-018-2099-0
   PubMed Web of Science ®Google Scholar
• Shrestha, R., & Copenhaver, M. (2018). Exploring the use of pre-exposure prophylaxis (PrEP) for HIV prevention among high-risk people who use drugs in treatment. Frontiers in Public Health, 6, 195. https://doi.org/10.3389/fpubh.2018.00195
   PubMed Web of Science ®Google Scholar
• Shrestha, R., Karki, P., Altice, F. L., Huedo-Medina, T. B., Meyer, J. P., Madden, L., & Copenhaver, M. (2017). Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment. Drug and Alcohol Dependence, 173, 107–116. https://doi.org/10.1016/j.drugalcdep.2016.12.023
   PubMed Web of Science ®Google Scholar
• Stewart, R. E., Mandell, D. S., & Beidas, R. S. (2021). Lessons from Maslow: Prioritizing funding to improve the quality of community mental health and substance use services. Psychiatric Services (Washington, DC), 72(10), 1219–1221. https://doi.org/10.1176/appi.ps.202000209
   PubMed Web of Science ®Google Scholar
• Wakeman, S. E., & Rich, J. D. (2018). Barriers to medications for addiction treatment: How stigma kills. Substance Use & Misuse, 53(2), 330–333. https://doi.org/10.1080/10826084.2017.1363238
   PubMed Web of Science ®Google Scholar